Xie and colleagues recently reported associations between clusterin expression and various pancreatic pathologies including pancreas adenocarcinoma, and concluded that clusterin positivity is related to improved survival, at least by univariate analysis [5]. The gene discussed is CLU; the disease is pancreatic adenocarcinoma.